Delivery Order SPE2DB22D3301-SPE2DB25FY9BA
- Not listed
- The Defense Logistics Agency awarded a $15,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TUKYSA 150 mg tablets (120 count units) with a ceiling value of $15,756.32. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a $7,846.58 delivery order to AmerisourceBergen Drug Corp for 60 tablets of TUKYSA 50 mg on August 8, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TUKYSA 50 mg tablets (60-count unit dose packaging) under a firm fixed-price contract valued at $6,306.64. This non-set-aside award, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- This is a $31,512.66 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TUKYSA 150 MG TABLET in a quantity of 120 tablets. The contract has an ultimate completion date of July 15, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug TUKYSA 150 MG TABLET, a specialty medication, with a ceiling value of $25,395.38 and a period of performance through May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,395.38, is for the delivery of TUKYSA 150 MG TABLET, a prescription pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $12,251.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562336121 TUKYSA 150 MG TABLETS in quantities of 60 tablets per unit. Performance will take place in Conshohocken, Pennsylvania under a schedule contract vehicle over a one month period concluding in mid-October 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order of oncology pharmaceutical products to support the Defense...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,674.74 firm-fixed-price delivery order covers the supply of TUKYSA 150 MG Tablets for an ultimate performance period ending on December 26, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded a $6,125.65 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563466162 TUKYSA 150 MG TABLET UU 60S. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9BADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TUKYSA is a prescription oncology medication, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need for specialized pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established role as a primary pharmaceutical vendor demonstrates its capability to efficiently fulfill federal medical procurement requirements through open competition, with delivery orders ranging significantly in value across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 8/8/25 |